• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

非典型中心性浆液性脉络膜视网膜病变

Atypical Central Serous Chorioretinopathy.

作者信息

Cebeci Zafer, Oray Merih, Bayraktar Şerife, Tuğal-Tutkun İlknur, Kır Nur

机构信息

İstanbul University İstanbul Faculty of Medicine, Department of Ophthalmology, İstanbul, Turkey.

出版信息

Turk J Ophthalmol. 2017 Aug;47(4):238-242. doi: 10.4274/tjo.38039. Epub 2017 Aug 15.

DOI:10.4274/tjo.38039
PMID:28845331
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5563555/
Abstract

Bullous central serous chorioretinopathy (CSCR) is a rare variant of CSCR characterized by severe serous retinal detachment which especially involves the inferior quadrants. Corticosteroid therapy administered for systemic or ocular misdiagnoses may induce and exacerbate CSCR. The purpose of this study was to report diagnosis and treatment results of an unusual case of bullous CSCR induced by systemic and periocular corticosteroid therapy received at another medical center due to a misdiagnosis of Vogt-Koyanagi-Harada disease.

摘要

大疱性中心性浆液性脉络膜视网膜病变（CSCR）是CSCR的一种罕见变异型，其特征为严重的浆液性视网膜脱离，尤其累及下方象限。因全身或眼部误诊而给予的皮质类固醇治疗可能诱发并加重CSCR。本研究的目的是报告一例因误诊为Vogt-小柳原田病而在另一家医疗中心接受全身及眼周皮质类固醇治疗后诱发的不寻常大疱性CSCR病例的诊断和治疗结果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a33b/5563555/08544a184755/TJO-47-238-g3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a33b/5563555/a0f5e68f74b8/TJO-47-238-g1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a33b/5563555/7145b9c34aca/TJO-47-238-g2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a33b/5563555/08544a184755/TJO-47-238-g3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a33b/5563555/a0f5e68f74b8/TJO-47-238-g1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a33b/5563555/7145b9c34aca/TJO-47-238-g2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a33b/5563555/08544a184755/TJO-47-238-g3.jpg

相似文献

1
Atypical Central Serous Chorioretinopathy.非典型中心性浆液性脉络膜视网膜病变
Turk J Ophthalmol. 2017 Aug;47(4):238-242. doi: 10.4274/tjo.38039. Epub 2017 Aug 15.
2
Management of Atypical Central Serous Chorioretinopathy Mimicking Vogt-Koyanagi-Harada Disease.疑似Vogt-小柳-原田病的非典型中心性浆液性脉络膜视网膜病变的管理
J Vitreoretin Dis. 2023 Feb 17;7(3):249-253. doi: 10.1177/24741264231152675. eCollection 2023 May-Jun.
3
Perfluorocarbon liquid-assisted external drainage in the management of central serous chorioretinopathy with bullous serous retinal detachment.全氟碳液体辅助外引流在治疗伴有大泡性浆液性视网膜脱离的中心性浆液性脉络膜视网膜病变中的应用
Chang Gung Med J. 2003 Oct;26(10):777-81.
4
Central serous chorioretinopathy, corticosteroids, and uveitis.中心性浆液性脉络膜视网膜病变、皮质类固醇和葡萄膜炎。
Ocul Immunol Inflamm. 2012 Apr;20(2):76-85. doi: 10.3109/09273948.2011.650776.
5
Bilateral exudative retinal detachment associated with central serous chorioretinopathy in a patient treated with corticosteroids.一名接受皮质类固醇治疗的患者出现双侧渗出性视网膜脱离并伴有中心性浆液性脉络膜视网膜病变。
Arch Soc Esp Oftalmol. 2017 Oct;92(10):481-485. doi: 10.1016/j.oftal.2017.01.002. Epub 2017 Feb 24.
6
Atypical Chronic Central Serous Chorioretinopathy Mimicking Vogt-Koyanagi-Harada Disease: Full Therapeutic Response to Half-Fluence Photodynamic Therapy.非典型慢性中心性浆液性脉络膜视网膜病变酷似 Vogt-Koyanagi-Harada 病：半强度光动力疗法的完全治疗反应。
Turk J Ophthalmol. 2022 Apr 28;52(2):147-152. doi: 10.4274/tjo.galenos.2022.93213.
7
Atypical Central Serous Chorioretinopathy Masquerading as Vogt-Koyanagi-Harada Disease: A Case Report.伪装成Vogt-小柳原田病的非典型中心性浆液性脉络膜视网膜病变：一例报告
Case Rep Ophthalmol. 2024 May 24;15(1):448-457. doi: 10.1159/000538736. eCollection 2024 Jan-Dec.
8
Treatment of persistent serous retinal detachment in Vogt-Koyanagi-Harada syndrome with intravitreal bevacizumab during the systemic steroid treatment.在全身使用类固醇治疗期间，玻璃体内注射贝伐单抗治疗Vogt-小柳-原田综合征持续性浆液性视网膜脱离
Retina. 2014 Mar;34(3):490-6. doi: 10.1097/IAE.0b013e3182a0e446.
9
Fibrotic scar formation in central serous chorioretinopathy developed during systemic treatment with corticosteroids.中心性浆液性脉络膜视网膜病变中的纤维化瘢痕形成发生于全身使用皮质类固醇治疗期间。
Graefes Arch Clin Exp Ophthalmol. 1998 Nov;236(11):876-9. doi: 10.1007/s004170050174.
10
Comparison of the Clinical Manifestations between Acute Vogt-Koyanagi-Harada Disease and Acute Bilateral Central Serous Chorioretinopathy.急性Vogt-小柳-原田病与急性双侧中心性浆液性脉络膜视网膜病变的临床表现比较
Korean J Ophthalmol. 2015 Dec;29(6):389-95. doi: 10.3341/kjo.2015.29.6.389. Epub 2015 Nov 25.

引用本文的文献

1
Bullous Central Serous Chorioretinopathy Associated With JAK Inhibitor Use.与使用JAK抑制剂相关的大疱性中心性浆液性脉络膜视网膜病变
J Vitreoretin Dis. 2025 Apr 25:24741264251337104. doi: 10.1177/24741264251337104.
2
Surgical Treatment of Bullous Exudative Retinal Detachment Secondary to Atypical Bilateral Central Serous Chorioretinopathy.手术治疗非典型双侧中心性浆液性脉络膜视网膜病变继发的大疱性渗出性视网膜脱离。
Turk J Ophthalmol. 2023 Dec 21;53(6):395-398. doi: 10.4274/tjo.galenos.2023.75233. Epub 2023 Nov 28.
3
Bilateral bullous central serous chorioretinopathy treated with PDT and eplerenone.

本文引用的文献

1
Oral eplerenone for treatment of chronic central serous chorioretinopathy: a case series.口服依普利酮治疗慢性中心性浆液性脉络膜视网膜病变：病例系列
Ophthalmic Surg Lasers Imaging Retina. 2015 Apr;46(4):439-44. doi: 10.3928/23258160-20150422-06.
2
Oral eplerenone for the management of chronic central serous chorioretinopathy.口服依普利酮治疗慢性中心性浆液性脉络膜视网膜病变
Int J Ophthalmol. 2015 Apr 18;8(2):310-4. doi: 10.3980/j.issn.2222-3959.2015.02.17. eCollection 2015.
3
Vogt-Koyanagi-Harada disease.伏格特-小柳-原田病
采用光动力疗法（PDT）和依普利酮治疗双侧大疱性中心性浆液性脉络膜视网膜病变。
Am J Ophthalmol Case Rep. 2022 Nov 2;28:101739. doi: 10.1016/j.ajoc.2022.101739. eCollection 2022 Dec.
4
Atypical Chronic Central Serous Chorioretinopathy Mimicking Vogt-Koyanagi-Harada Disease: Full Therapeutic Response to Half-Fluence Photodynamic Therapy.非典型慢性中心性浆液性脉络膜视网膜病变酷似 Vogt-Koyanagi-Harada 病：半强度光动力疗法的完全治疗反应。
Turk J Ophthalmol. 2022 Apr 28;52(2):147-152. doi: 10.4274/tjo.galenos.2022.93213.
5
Bullous Central Serous Chorioretinopathy: A Rare and Atypical Form of Central Serous Chorioretinopathy. A Systematic Review.大疱性中心性浆液性脉络膜视网膜病变：一种罕见且非典型的中心性浆液性脉络膜视网膜病变。系统评价
Pharmaceuticals (Basel). 2020 Aug 28;13(9):221. doi: 10.3390/ph13090221.
6
Central Serous Chorioretinopathy: A Complication Associated with Behçet’s Disease Treatment.中心性浆液性脉络膜视网膜病变：一种与白塞病治疗相关的并发症。
Turk J Ophthalmol. 2019 Feb 28;49(1):40-43. doi: 10.4274/tjo.galenos.2018.83479.
7
Photodynamic therapy for bullous retinal detachment: a single-center experience of case series with a 6-month follow-up study.光动力疗法治疗大泡性视网膜脱离：一项单中心病例系列6个月随访研究经验
Graefes Arch Clin Exp Ophthalmol. 2018 Aug;256(8):1429-1439. doi: 10.1007/s00417-018-4015-8. Epub 2018 Jun 4.
Ocul Immunol Inflamm. 2014 Aug;22(4):249-52. doi: 10.3109/09273948.2014.939530.
4
Choroidal imaging: A review.脉络膜成像：综述
Saudi J Ophthalmol. 2014 Apr;28(2):123-8. doi: 10.1016/j.sjopt.2014.03.004. Epub 2014 Mar 20.
5
Central serous chorioretinopathy: update on pathophysiology and treatment.中心性浆液性脉络膜视网膜病变：发病机制和治疗的最新进展。
Surv Ophthalmol. 2013 Mar-Apr;58(2):103-26. doi: 10.1016/j.survophthal.2012.07.004.
6
Half-fluence photodynamic therapy in chronic central serous chorioretinopathy.半剂量光动力疗法治疗慢性中心性浆液性脉络膜视网膜病变。
Retina. 2013 Feb;33(2):316-23. doi: 10.1097/IAE.0b013e318280769c.
7
Central serous chorioretinopathy, corticosteroids, and uveitis.中心性浆液性脉络膜视网膜病变、皮质类固醇和葡萄膜炎。
Ocul Immunol Inflamm. 2012 Apr;20(2):76-85. doi: 10.3109/09273948.2011.650776.
8
Half-dose verteporfin photodynamic therapy for bullous variant of central serous chorioretinopathy: a case report.半剂量维替泊芬光动力疗法治疗中心性浆液性脉络膜视网膜病变大疱性变体：一例报告
J Med Case Rep. 2011 May 26;5:208. doi: 10.1186/1752-1947-5-208.
9
Development of bullous retinal detachment during systemic corticosteroid treatment.全身用皮质类固醇治疗期间大疱性视网膜脱离的发生
Graefes Arch Clin Exp Ophthalmol. 2011 Dec;249(12):1905-7. doi: 10.1007/s00417-010-1582-8. Epub 2010 Dec 3.
10
Surgical management of bilateral exudative retinal detachment associated with central serous chorioretinopathy.与中心性浆液性脉络膜视网膜病变相关的双侧渗出性视网膜脱离的手术治疗
Korean J Ophthalmol. 2006 Jun;20(2):131-8. doi: 10.3341/kjo.2006.20.2.131.